MG
Melanie Gilbertabout 4 years ago
What is the BNT-162b2 coronavirus disease 2019 (COVID-19) vaccine?
Top rated comment
about 4 years ago
BNT-162b2 (Pfizer) is derived from mRNA method of technology. It is a nucleoside-modified messenger RNA (modRNA) vaccine. BNT-162b2 vaccine contains RBD i.e. receptor-binding antigen of SARS-CoV-2. Dose series = 2-dose series. Both doses have difference of 21 days. Vaccine efficacy = 95% Safety concerns = none
Other commentsSign in to post comments. You don't have an account? Sign up now!
Related posts
Which coronavirus disease 2019 (COVID-19) vaccines are still in earlier phases of development?Which noninjectable coronavirus disease 2019 (COVID-19) vaccines are under development?Which vaccines are being investigated for coronavirus disease 2019 (COVID-19) prevention?Can a patient with SLE get vaccine against COVID-19What are viral variants in COVID-19 and how are they affecting vaccine immune responses?How many vaccines are under development for coronavirus disease 2019 (COVID-19)?What are the mixed views about COVID-19 vaccine? How COVID threatens the brain?Complications of Covid-19Symptoms of Covid-19
